Linde India share news, announcements and annual reports

NSE: LINDEINDIABSE: 523457Chemicals & PetrochemicalsMid Cap

Linde India Limited · Formerly BOC India · Face value ₹10 · Listed Jan 1992 on BSE, Jun 1999 on NSE

₹5,651.50₹66.50 (1.16%)BSE ₹5,648.65

Share price at the NSE close on 30 Oct 2026. Previous close ₹5,718.00.

30 Oct: open ₹5,720.00, high ₹5,725.50, low ₹5,544.00

52-week range of traded prices to 30 Oct 2026

₹5,544.00Low, 30 Oct 2026₹8,049.00High, 7 May 2026

Next results date: the board meets on 3 Nov 2026 to consider: financial results. The notice · Results calendar

Market cap: ₹48,198 Cr178th largest listed
P/E: 88.22
P/B: 11.30
Dividend yield: 0.21%
ROE: 13.5%
ROCE: 15.7%
Debt to equity: 0.00
Volume, NSE: 34,458

Linde India board meetings

110 filed, newest first. Page 1 of 3.

Oct 2026
- 26 Oct · Board meeting
  To consider and approve the financial results for the period ended September 30, 2026
Aug 2026
- 11 Aug · Board meeting
  Outcome of Board Meeting held on August 11, 2026.
- 10 Aug · Board meeting
  Please find enclosed our letter no. Sect/68 dated 10 August 2026 regarding updates on adjournment of Board Meeting for approval of the Unaudited Financial Results of the Company for the quarter ended 30 June 2026. You are requested to please take the above on record.
- 3 Aug · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2026
  Not held on this date
May 2026
- 15 May · Board meeting
  This is to inform you that a meeting of the Board of Directors of the Company has been scheduled to be held on Saturday, 30 May 2026, to inter-alia, consider and approve the Audited Standalone and Consolidated Financial Results of the Company, for the quarter and financial year ended 31 March 2026 and to recommend dividend, if any, on the equity shares of the Company for the financial year ended 31 March 2026.
Feb 2026
- 9 Feb · Board meeting
  Board meeting held on February 09, 2026.
- 2 Feb · Board meeting
  To consider and approve the financial results for the period ended December 31, 2025
Oct 2025
- 27 Oct · Board meeting
  To consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30 September 2025
Jul 2025
- 25 Jul · Board meeting
  To consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended 30 June 2025
May 2025
- 23 May · Board meeting
  Financial results for the period ended March 31, 2025.
- 16 May · Board meeting
  To consider and approve the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended 31 March 2025
Feb 2025
- 7 Feb · Board meeting
  Outcome of Board Meeting held on February 07, 2025.
Jan 2025
- 28 Jan · Board meeting
  Board Meeting for approval of Unaudited Standalone and Consolidated Financial Results for the third quarter and nine months ended 31 December 2024
Nov 2024
- 7 Nov · Board meeting
  Outcome of Board Meeting held on 7 November 2024.
Oct 2024
- 28 Oct · Board meeting
  To consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30 September 2024
Sep 2024
- 23 Sep · Board meeting
  Outcome of Board Meeting held on September 23, 2024.
Aug 2024
- 6 Aug · Board meeting
  Board meeting held on August 06, 2024.
Jul 2024
- 29 Jul · Board meeting
  Board Meeting for approval of Unaudited Annual Standalone and Consolidated Financial Results for the quarter ended 30 June 2024
May 2024
- 17 May · Board meeting
  Board Meeting for approval of Audited Annual Standalone and Consolidated Financial Results for the quarter and year ended 31 March 2024
Feb 2024
- 5 Feb · Board meeting
  Outcome of Board Meeting held on February 05, 2024.
Jan 2024
- 24 Jan · Board meeting
  To consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the third quarter and nine months ended 31 December 2023.
Nov 2023
- 6 Nov · Board meeting
  Board meeting held on November 06, 2023.
Oct 2023
- 28 Oct · Board meeting
  To consider and approve the financial results for the quarter and half year ended 30 September 2023
Jul 2023
- 28 Jul · Board meeting
  To consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30 June 2023.
May 2023
- 12 May · Board meeting
  To consider and approve the Audited Annual Standalone and Consolidated Financial Results of the Company (with its Joint Venture Companies) for the quarter and 15 months period ended 31 March 2023 and to recommend dividend, if any, on the equity shares of the Company for the 15 months period ended 31 March 2023.
Feb 2023
- 13 Feb · Board meeting
  Outcome of Board Meeting held on February 13, 2023.
Jan 2023
- 30 Jan · Board meeting
  To consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the fourth quarter ended 31 December 2022
Nov 2022
- 14 Nov · Board meeting
  Board Meeting held on 14-Nov-2022 to consider the standalone and consolidated financial results of the Company for the period ended September 2022
- 10 Nov · Board meeting
  Postponement of Board Meeting for approval of the unaudited financial results for the 3rd quarter and nine months ended 30 September 2022.
Oct 2022
- 17 Oct · Board meeting
  Board Meeting to be held on 10-Nov-2022 to consider and approve Unaudited Standalone and Consolidated Financial Results for the third quarter and nine months ended 30 September 2022
  Not held on this date
Aug 2022
- 9 Aug · Board meeting
  Board Meeting held on 09-Aug-2022 to consider financial statements for the period ended June 2022
Jul 2022
- 28 Jul · Board meeting
  Board Meeting to be held on 09-Aug-2022 to consider and approve unaudited financial results for the second quarter and half year ended 30 June 2022.
May 2022
- 13 May · Board meeting
  Board Meeting held on 13-May-2022 to consider financial statements for the period ended March 2022
- 2 May · Board meeting
  Board Meeting to be held on 13-May-2022 to consider Unaudited Standalone and Consolidated financial results of the Company for the first quarter ended 31 March 2022.
Feb 2022
- 24 Feb · Board meeting
  Board Meeting held on 24-Feb-2022 to consider financial statements for the period ended December 2021 and Dividend
- 14 Feb · Board meeting
  To consider and approve the Audited Annual Standalone and Consolidated Financial Results of the Company (with its Joint Venture Companies) for the year ended on 31 December 2021 and to recommend dividend, if any, on the equity shares in the Company for the said financial year.
Nov 2021
- 12 Nov · Board meeting
  Board meeting held on November 12, 2021.
Oct 2021
- 29 Oct · Board meeting
  To consider and approve the financial results for the period ended September 30, 2021
Aug 2021
- 10 Aug · Board meeting
  Board meeting held on August 10, 2021.
- 3 Aug · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2021
May 2021
- 11 May · Board meeting
  Board meeting held on May 11, 2021.
Apr 2021
- 28 Apr · Board meeting
  To consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the first quarter ended 31 March 2021
Feb 2021
- 18 Feb · Board meeting
  This is to inform you that a meeting of the Board of Directors of the Company has been scheduled to be held on Monday, 1 March 2021, to inter alia, consider and approve the Audited Annual Standalone and Consolidated Financial Results of the Company (with its Joint Venture Companies) for the year ended on 31 December 2020 and to recommend dividend, if any, in respect of the equity shares of the Company for the said financial year.
Nov 2020
- 11 Nov · Board meeting
  Board meeting held on November 11, 2020.
- 3 Nov · Board meeting
  To consider and approve the unaudited standalone and consolidated financial results of the Company for the third quarter ended 30 September 2020
Jul 2020
- 30 Jul · Board meeting
  Updates on Outcome of the Board meeting held on July 30, 2020.
- 17 Jul · Board meeting
  To consider and approve the unaudited standalone and consolidated financial results for the second quarter and half year ended 30 June 2020
Apr 2020
- 20 Apr · Board meeting
  Board meeting held on April 20, 2020 to consider and approve UFR for Q1 2020.
- 13 Apr · Board meeting
  To inter-alia consider and approve the unaudited standalone and consolidated financial results for the first quarter ended 31 March 2020.
Feb 2020
- 14 Feb · Board meeting
  This is to inform you that a meeting of the Board of Directors of the Company has been scheduled to be held on Monday, 24 February 2020, to inter-alia, consider and approve the Audited Annual Standalone and Consolidated Financial Results of the Company (with its Joint Venture Company) for the year ended on 31 December 2019 and to recommend dividend, if any, in respect of the equity shares of the Company for the said financial year.This may please be treated as compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Linde India board meetings

Oct 2026

Aug 2026

May 2026

Feb 2026

Oct 2025

Jul 2025

May 2025

Feb 2025

Jan 2025

Nov 2024

Oct 2024

Sep 2024

Aug 2024

Jul 2024

May 2024

Feb 2024

Jan 2024

Nov 2023

Oct 2023

Jul 2023

May 2023

Feb 2023

Jan 2023

Nov 2022

Oct 2022

Aug 2022

Jul 2022

May 2022

Feb 2022

Nov 2021

Oct 2021

Aug 2021

May 2021

Apr 2021

Feb 2021

Nov 2020

Jul 2020

Apr 2020

Feb 2020